Log in
Enquire now
Enara Bio

Enara Bio

TCR-based immunotherapies developer targeting novel dark antigens for cancer patients.

OverviewStructured DataIssuesContributors

Contents

enarabio.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Drug discovery
Drug discovery
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
Engineering
Engineering
Location
Oxfordshire
Oxfordshire
B2X
B2B
B2B
0
CEO
‌
Kevin Pojasek
Legal Name
Enara Bio Limited
Number of Employees (Ranges)
51 – 2000
Email Address
info@enarabio.com
Investors
Pfizer Venture Investments
Pfizer Venture Investments
M Ventures
M Ventures
SV Health Investors
SV Health Investors
RA Capital Management
RA Capital Management
Samsara BioCapital
Samsara BioCapital
Founded Date
2016
Total Funding Amount (USD)
32,500,000
Latest Funding Round Date
October 3, 2024
CFO
‌
Dave Watson
Latest Funding Type
Series B
Series B
Country
United Kingdom
United Kingdom

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
32,500,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Enara Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.